WIN 55,212-2

 

WIN 55,212-2 is Unscheduled in the United States.

Addictive Potential: Unknown

Emergency Room Visits Yearly: Unknown

Mandatory Minimum Sentence: Unknown

Mechanism of Action: Cannabinoid receptor agonist

 

Overview:

WIN 55212-2 (mesylate) is a potent aminoalkylindole cannabinoid (CB) receptor agonist with a Ki of 3.3 and 62.3 nM for human recombinant CB1 and CB2 receptors, respectively. WIN 55212-2 is a full agonist at the CB1 receptor and has higher affinity than THC for the CB1 receptor. It has been found to be a potent analgesic in a rat model of neuropathic pain. It activates p42 and p44 MAP kinase via receptor-mediated signaling.

WIN 55,212-2 is implicated in preventing the inflammation caused by Amyloid beta proteins involved in Alzheimer's Disease, in addition to preventing cognitive impairment and loss of neuronal markers. This anti-inflamatory action is induced through the agonization of cannabinoid receptors which prevents microglial activation that elicits the inflammation. Additionally, cannabinoids completely abolish neurotoxicity related to microglia activation in rat models.

*View and Submit Your Experiences in the New Community Trip Reports Area*

Side Effects and Adverse Reactions:

WIN 55,212-2 is a research chemical. Research chemicals are experimental chemicals that are not approved for human consumption. This is because not enough data exists currently about their side effects, adverse reactions, long term damage, addiction potential, etc. Although some people are willing to ingest research chemicals, it is not reasonable to assume that they are in any way safe to use recreationally.

 

WIN 55,212-2 and Drug Tests:

WIN 55,212-2 is a synthetic cannabinoid that currently cannot be detected with drug tests. This is because of how drug tests work. The basic concept is that your body attempts to break down any drugs you ingest. Metabolites are formed as part of this process; testing looks for the specific types of metabolites that could only occur as a result of drug taking. There is currently (as of Nov, 2009) no test that tests for the metabolites of synthetic cannabinoids. Rumor has it that scientists are developing a drug test that tests for them, although, the development and implementation process could take years.

 

E-books:

The NeuroSoup Trip Guide - This e-book discusses: Set, Setting, and Preparation for a Trip, Tips for Tripsitters, Aspects of the Entheogenic Experience, Working with Difficult Experiences, and Integration. Adverse psychological reactions, like flashbacks and HPPD, may potentially be avoided with proper preparation before and integration after entheogenic journeys. Thus, this e-book serves the purpose of harm reduction education. For clarity, NeuroSoup does not advocate the use of illegal, quasi-legal, or legal drugs. All substances that affect the central nervous system (legal or illegal) can have side effects, adverse reactions, and negative interactions with other drugs. Abstinence is always the best way to protect one's health.

 

More Info:

List of Synthetic Cannabinoids

Buy NeuroSoup Gear